← FDA Drug Approvals (Drugs@FDA)
BLINCYTO
BLA · Biologics License Application · Sponsor: AMGEN · Approved 2014-12-03
Drug application
- FDA Application #
BLA125557- Application type
- Biologics License Application
- Brand name
- BLINCYTO
- Generic name
- BLINATUMOMAB
- Active ingredients
- BLINATUMOMAB
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- AMGEN
- Manufacturer
- Amgen, Inc
- First approval
- 2014-12-03
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown